Form 4: Director Lawrence Taylor III Receives CaliberCos Options
Statement of Changes in Beneficial Ownership
Director Lawrence X. Taylor III was granted 23,658 employee stock options as part of his director compensation package.
Summary
- Director Lawrence X. Taylor III received a grant of 23,658 employee stock options on May 20, 2026.
- The options have an exercise price of $1.02 per share.
- The options are exercisable immediately and expire on May 20, 2036.
- This grant is part of the director's compensation under the Issuer's 2024 Equity Incentive Plan.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative disclosure regarding director compensation with no immediate impact on company operations.
Positives
- Alignment of director interests with shareholders through equity-based compensation.
- The grant utilizes the 2024 Equity Incentive Plan, indicating active use of established compensation structures.
Negatives
- The grant increases potential future dilution for existing shareholders upon exercise.
Risks
- Potential dilution of equity value if options are exercised.
- Market volatility affecting the value of the underlying Class A Common Stock.
Future Outlook
The filing does not provide forward-looking financial guidance, focusing solely on the disclosure of director compensation.
Management Comments
- The options represent a portion of the Reporting Person's compensation as a director of the Issuer.
Industry Context
StockSavvy.ai notes that equity-based compensation for directors is a standard practice in the financial services and asset management sectors to ensure long-term alignment with corporate performance.
Comparison to Industry Standards
- The use of multi-year equity incentive plans is consistent with standard corporate governance practices for publicly traded companies.
- The structure of the grant aligns with typical director compensation packages found in small-cap financial firms.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation | Grant of equity-based compensation to a director. | 05/20/2026 | Neutral; standard practice for director retention and alignment. |
Stakeholder Impact
- Shareholders: Potential for minor dilution upon exercise of options.
- Director: Increased financial stake in the company's long-term performance.
Next Steps
- Potential future exercise of options by the director.
Key Dates
| Date | Description |
|---|---|
| 06/25/2024 | Grant date of previous option tranche |
| 09/30/2024 | Grant date of previous option tranche |
| 12/16/2024 | Grant date of previous option tranche |
| 03/17/2025 | Grant date of previous option tranche |
| 06/17/2025 | Grant date of previous option tranche |
| 09/16/2025 | Grant date of previous option tranche |
| 05/20/2026 | Transaction date of new option grant |
| 05/21/2026 | Filing date of Form 4 |
| 05/20/2036 | Expiration date of new option grant |
Keywords
CaliberCos, CWD, Form 4, Director Compensation, Stock Options, Insider Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.